Detalles de la búsqueda
1.
Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.
Mol Oncol
; 16(10): 1969-1985, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34866317
2.
Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer.
Clin Cancer Res
; 26(15): 3947-3957, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32312891
3.
Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA.
Sci Rep
; 9(1): 12620, 2019 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31477768
4.
Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial.
Clin Cancer Res
; 24(23): 5860-5872, 2018 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30082476
5.
A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic Cancers.
Clin Cancer Res
; 24(9): 2050-2059, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29066505
Resultados
1 -
5
de 5
1
Próxima >
>>